#CCSGuidelines #FH @CJC_JCC
And here is the link to the most recent @SCC_CCS Guideline on Management of FH Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018 https://t.co/PFUszi0AkW
Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018. https://t.co/0cT5QiO95k
#cbridge #FH affects 1 in 250 individuals worldwide, and of the approximately 145,000 #Canadians estimated to have FH, most are undiagnosed. Learn more about the management of #FH in the #CCS latest publication. https://t.co/440rn04Aou
RT @SCC_CCS: FH affects 1 in 250 individuals worldwide, and of the approximately 145,000 Canadians estimated to have FH, most are undiagnos…
RT @SCC_CCS: La HF affecte une personne sur 250 dans le monde et on estime que sur les 145 000 Canadiens atteints de la HF, la plupart n’on…
RT @SCC_CCS: FH affects 1 in 250 individuals worldwide, and of the approximately 145,000 Canadians estimated to have FH, most are undiagnos…
La HF affecte une personne sur 250 dans le monde et on estime que sur les 145 000 Canadiens atteints de la HF, la plupart n’ont pas reçu de diagnostic. Apprenez-en plus sur la gestion de la #HF dans la dernière publication de la SCC. https://t.co/hiwOopd0b
FH affects 1 in 250 individuals worldwide, and of the approximately 145,000 Canadians estimated to have FH, most are undiagnosed. Learn more about the management of #FH in the CCS’ latest publication. https://t.co/hiwOopd0ba
Did you know that FH is the most common monogenic disorder causing premature atherosclerotic #CVD? Learn more about the new Canadian definition for #FH and about the tools for clinicians to make a diagnosis! https://t.co/hiwOopd0ba
RT @MuinJKhoury: The 2018 Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia includes a new case definitio…
L’énoncé de position de la SCC sur l’hypercholestérolémie familiale : la mise à jour de 2018 est maintenant disponible. Lisez les plus récentes découvertes! @CJC_JCC https://t.co/hiwOopd0ba
The CCS’ Position Statement on Familial Hypercholesterolemia: Update 2018 is now available. Read the latest findings! @CJC_JCC https://t.co/hiwOopd0ba
RT @CJC_JCC: Check out the latest @CCS_SCC Position Statement on Familial Hypercholesterolemia! #HotOffThePress #cholesterol @LiamBrunham @…
RT @CJC_JCC: Check out the latest @CCS_SCC Position Statement on Familial Hypercholesterolemia! #HotOffThePress #cholesterol @LiamBrunham @…
RT @MuinJKhoury: The 2018 Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia includes a new case definitio…
RT @MuinJKhoury: The 2018 Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia includes a new case definitio…
The 2018 Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia includes a new case definition and tools for clinicians to make a diagnosis of FH. #KnowFH https://t.co/qvm3H4FYGz https://t.co/22dZru3clk
An important problem that demands attentive care. Powerful new diagnostic and therapeutic tools are available and need to be applied to control #cholesterol and prevent #atherosclerosis. See also Ruel et all @CJC_JCC https://t.co/R6w1vUt073. @LiamBrunham @
RT @CJC_JCC: Check out the latest @CCS_SCC Position Statement on Familial Hypercholesterolemia! #HotOffThePress #cholesterol @LiamBrunham @…
Check out the latest @CCS_SCC Position Statement on Familial Hypercholesterolemia! #HotOffThePress #cholesterol @LiamBrunham @GBJohnMancini1 https://t.co/BKlrsZJjy1 https://t.co/CEosEGv7v8
RT @AngoulvantD: Health Canada has approved 2 PCSK9 monoclonal antibodies administered subcutaneously for reducing LDL-C levels in patients…
New 2018 Canadian Guidelines on Familial Hypercholesterolemia: https://t.co/fhYTL2skSs https://t.co/fhYTL2skSs
Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018 https://t.co/tkH9YJM2vj
RT @AngoulvantD: Health Canada has approved 2 PCSK9 monoclonal antibodies administered subcutaneously for reducing LDL-C levels in patients…
RT @AngoulvantD: Health Canada has approved 2 PCSK9 monoclonal antibodies administered subcutaneously for reducing LDL-C levels in patients…
RT @AngoulvantD: Health Canada has approved 2 PCSK9 monoclonal antibodies administered subcutaneously for reducing LDL-C levels in patients…
RT @AngoulvantD: Health Canada has approved 2 PCSK9 monoclonal antibodies administered subcutaneously for reducing LDL-C levels in patients…
Happy to share the new @SCC_CCS Position Statement on Familial Hypercholesterolemia. Such a privilege to work on this project led by co-chairs Jacques Genest and Rob Hegele, and many great colleagues across Canada. https://t.co/X9jFbcZvkd
RT @StanleyNattel: Familial #hypercholesterolemia (#FH) is more common than usually recognized, affecting >100000 #Canadians and >1M Americ…
RT @StanleyNattel: Familial #hypercholesterolemia (#FH) is more common than usually recognized, affecting >100000 #Canadians and >1M Americ…
RT @AngoulvantD: Health Canada has approved 2 PCSK9 monoclonal antibodies administered subcutaneously for reducing LDL-C levels in patients…
RT @StanleyNattel: Familial #hypercholesterolemia (#FH) is more common than usually recognized, affecting >100000 #Canadians and >1M Americ…
RT @lipiddoc: Thanks @DrJulieStPierre for sharing -- good friend of @nationallipid and @NLAFoundation @NLAWIL -- Look forward to reading t…
RT @lipiddoc: Thanks @DrJulieStPierre for sharing -- good friend of @nationallipid and @NLAFoundation @NLAWIL -- Look forward to reading t…
RT @lipiddoc: Thanks @DrJulieStPierre for sharing -- good friend of @nationallipid and @NLAFoundation @NLAWIL -- Look forward to reading t…
RT @lipiddoc: Thanks @DrJulieStPierre for sharing -- good friend of @nationallipid and @NLAFoundation @NLAWIL -- Look forward to reading t…
RT @StanleyNattel: Familial #hypercholesterolemia (#FH) is more common than usually recognized, affecting >100000 #Canadians and >1M Americ…
RT @StanleyNattel: Familial #hypercholesterolemia (#FH) is more common than usually recognized, affecting >100000 #Canadians and >1M Americ…
Familial #hypercholesterolemia (#FH) is more common than usually recognized, affecting >100000 #Canadians and >1M Americans, with major #health consequences. See @LiamBrunham et al for @SCC_CCS FH guidelines for FH diagnosis and Rx https://t.co/PEhIn
Health Canada has approved 2 PCSK9 monoclonal antibodies administered subcutaneously for reducing LDL-C levels in patients with FH who have not achieved target LDL-C levels despite maximally tolerated doses of statins. https://t.co/t9bFGSafBS
@hanabangash you might find this interesting!
RT @lipiddoc: Thanks @DrJulieStPierre for sharing -- good friend of @nationallipid and @NLAFoundation @NLAWIL -- Look forward to reading t…
Thanks @DrJulieStPierre for sharing -- good friend of @nationallipid and @NLAFoundation @NLAWIL -- Look forward to reading this , especially the section on children ! Pls Share @NYUCVDPrevent @drpablocorral @gina_lundberg @ErinMichos @MHealthTeam @rauldsf
Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018 https://t.co/0odK0ZN0jR